Skip to main content
. Author manuscript; available in PMC: 2022 Feb 7.
Published in final edited form as: Vaccine. 2019 Jul 11;37(35):5111–5120. doi: 10.1016/j.vaccine.2019.05.089

Fig. 3.

Fig. 3.

Hepatitis B vaccination doses administered through the pilot by setting type and dose in vaccine series, September 2012-September 2015.13

Footnotes: Awardees reported doses administered by setting and dose-number of the 3-dose series. This figure includes awardees who did and did not track individual patient-level dose-series completion.

1Abbreviations: STD = Sexually transmitted disease; MSM = men who have sex with men; IDU = injection drug user.

2Data regarding doses administered that did not include which dose in the series was given were excluded from this figure. Data tracking issues (e.g., coding errors in distinguishing doses funded by the pilot and doses funded by other sources) resulted in some over- and under-counting of doses among awardees.

3“Other” includes community-based organizations (e.g., those that serve Africans, Asian/Pacific Islanders), rural health clinics, community health clinics, mental health clinics, family planning clinics, HIV/AIDS resource fairs, health fairs, homeless shelters, college events, college health fairs, a celebrity rapper, and community outreach events (e.g., community health fair, block parties).